Any allogeneic stem cell transplant recipient = 14 years of age and = 60 years of age
Bilirubin/ SGOT/SGPT < 5 × upper normal limits.
Creatinine < 2 × upper normal limits.
Ejection fraction = 50%, no severe arrhythmia.
Estimated life expectancy = 6 months.
Patients' CMV-DNA = 1000cp/ml in treatment group and being negative in prophylactic group.
